VIVIMEDLAB.NSVIVIMEDLAB.NSNSE
Loading
EBITDA Margin Over TimeContracting
Percentile Rank14
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Percentile
P14
Within normal range
vs 5Y Ago
-4.9x
Contraction
Streak
2 yr
Consecutive growthContracting
PeriodValueYoY Change
2025-7.46%+54.9%
2024-16.55%+83.3%
2023-99.37%-3372.3%
2022-2.86%-173.4%
20213.90%+154.3%
20201.53%-89.3%
201914.38%-24.8%
201819.11%-33.7%
201728.81%+59.6%
201618.05%-